Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/27/2002WO2002102837A2 Marker for identifying hematopoietic stem cells
12/27/2002WO2002102836A2 Moraxella (branhamella) catarrhalis antigens
12/27/2002WO2002102833A1 Novel endomorphine derivatives
12/27/2002WO2002102831A1 Process for extracting collagen from marine invertebrates
12/27/2002WO2002102830A1 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
12/27/2002WO2002102829A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
12/27/2002WO2002102767A2 Bot1: target for antifungal agents
12/27/2002WO2002102417A1 Vector and the use thereof in gene therapy methods
12/27/2002WO2002102412A2 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/27/2002WO2002102411A2 Method for treating psoriasis by using an il-17d antagonist
12/27/2002WO2002102410A1 Subunit vaccines and processes for the production thereof
12/27/2002WO2002102408A1 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
12/27/2002WO2002102404A1 Uses of cytokines
12/27/2002WO2002102402A1 Anticancer agents
12/27/2002WO2002102399A2 Mucosal repair by tff2 peptides
12/27/2002WO2002102324A2 Anti-arthropod vector vaccines methods of selecting and uses thereof
12/27/2002WO2002102321A2 Novel proteins and nucleic acids encoding same
12/27/2002WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma
12/27/2002WO2002102319A2 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
12/27/2002WO2002102318A2 Eglin c based drugs for treatment of disease
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102302A2 Method of preparing and formulations including hydrolyzed jojoba protein
12/27/2002WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
12/27/2002WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002102144A1 Cell deah-inducible model nonhuman animal
12/27/2002WO2002095036A3 A novel intein and uses thereof
12/27/2002WO2002092805A8 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tuberculosis
12/27/2002WO2002074071A3 Transgenic animal model of ige-mediated allergic responses
12/27/2002WO2002070658A9 Compositions and methods for increasing amino acid absorption in mammals
12/27/2002WO2002066072A9 Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002WO2002056831A9 Immunogenic proteoliposomes, and uses thereof
12/27/2002WO2002055720A9 Materials and methods relating to protein aggregation in neurodegenerative disease
12/27/2002WO2002052003A3 Regulation of human calcium channel
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002042452A3 Adapter protein and gene encoding it
12/27/2002WO2002040545A3 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
12/27/2002WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
12/27/2002WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
12/27/2002WO2002038795A3 Braf35 protein and brca2/braf35 complex and methods of use
12/27/2002WO2002029075A8 Multiple inducible gene regulation system
12/27/2002WO2002029052A3 Regulation of human secretin receptor-like gpcr
12/27/2002WO2002024908A9 Novel tissue-specific secretory polypeptide and dna thereof
12/27/2002WO2002024869A3 Elicitor of fungal origin and method for its preparation
12/27/2002WO2002020755A3 Phenol oxidizing enzyme variants
12/27/2002WO2002020610A3 Conformationally constrained labeled peptides for imaging and therapy
12/27/2002WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002WO2002016396A3 Mammalian rh type b glycoprotein ion transporter
12/27/2002WO2002012279A3 Schizophrenia related gene and protein
12/27/2002WO2002010414A3 Expression of biologically active polypeptides in duckweed
12/27/2002WO2002010391A3 18610, a human transient receptor and uses thereof
12/27/2002WO2002010390A3 57250, a human sugar transporter family member and uses thereof
12/27/2002WO2002010379B1 Modified cea and uses thereof
12/27/2002WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
12/27/2002WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/27/2002WO2001094587A3 Extracellular messengers
12/27/2002WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002WO2001085937A3 Regulator of g protein signalling (rgs8)
12/27/2002WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
12/27/2002WO2001083809A9 Cell membrane nucleic acid transport channel complex
12/27/2002WO2001081546A9 CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS
12/27/2002WO2001081404A3 INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF
12/27/2002WO2001077348A8 Ketogulonigenium endogenous plasmids
12/27/2002WO2001076532A9 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
12/27/2002WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002WO2001070812A3 Regulation of human histamine h2-like g protein-coupled receptor
12/27/2002WO2001058947A9 Lipophilin complexes for use in cancer diagnosis and therapy
12/27/2002WO2001057217A9 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
12/27/2002WO2001034631A3 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF
12/27/2002WO2000052184A9 Anti-neoplastic compositions and uses thereof
12/27/2002CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002CA2680376A1 Flax (linum usitatissimum l.) seed-specific promoters
12/27/2002CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002CA2455254A1 Moraxella (branhamella) catarrhalis antigens
12/27/2002CA2451465A1 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002CA2451058A1 Novel nucleic acids, polypeptides, methods of making, and uses thereof
12/27/2002CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002CA2450732A1 Stabilized proteins with engineered disulfide bonds
12/27/2002CA2450700A1 Trx1 antibody and uses therefor
12/27/2002CA2450678A1 Novel polypeptide and use thereof
12/27/2002CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002CA2450658A1 Essential and important genes of pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents
12/27/2002CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002CA2450442A1 Novel ligand and dna thereof
12/27/2002CA2450288A1 Novel human transporter proteins and polynucleotides encoding the same
12/27/2002CA2450159A1 Methods for modulating gap junctions
12/27/2002CA2450127A1 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
12/27/2002CA2450125A1 Gene therapy for hemophilia a
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2449909A1 Male contraceptives
12/27/2002CA2448872A1 Peptides involved in the transmission of prionization between heterogenous erf3 proteins
12/27/2002CA2448501A1 Flax (linum usitatissimum l.) seed-specific promoters
12/27/2002CA2448284A1 Gene expression during meningococcus adhesion
12/27/2002CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002CA2445261A1 Human tachykinin-related splice variants and compositions thereof
1 ... 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 ... 2916